Trial intelligence / Profile preview

Goliath: Prednisolone for Craving During Heroin and Stimulant Detoxification

NCT02935101Phase 2Terminated

Start
Oct 2016
Primary completion
May 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of prednisolone in opioid use disorder (OUD), cocaine dependence. Started Oct 2016; status: terminated.

02

Drugs

prednisolone
03

Conditions

opioid use disorder (OUD)cocaine dependence

Beyond the preview

Go deeper on NCT02935101.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02935101.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call